Alison Marker

1.6k total citations
31 papers, 774 citations indexed

About

Alison Marker is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Alison Marker has authored 31 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 8 papers in Molecular Biology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Alison Marker's work include Cancer, Hypoxia, and Metabolism (7 papers), Adrenal and Paraganglionic Tumors (7 papers) and Hormonal Regulation and Hypertension (4 papers). Alison Marker is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Adrenal and Paraganglionic Tumors (7 papers) and Hormonal Regulation and Hypertension (4 papers). Alison Marker collaborates with scholars based in United Kingdom, United States and Malaysia. Alison Marker's co-authors include Ann Colosia, M. Raafat El‐Maghrabi, Lisa Happerfield, S.J. Pilkis, Elena Azizan, Morris J. Brown, Junhua Zhou, J Pilkis, Aksel Lange and Albert Tauler and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Alison Marker

31 papers receiving 745 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Marker United Kingdom 14 354 311 287 200 108 31 774
Catherine Deveaud France 9 68 0.2× 401 1.3× 545 1.9× 184 0.9× 111 1.0× 9 780
Agnieszka Adamek Poland 12 87 0.2× 147 0.5× 305 1.1× 147 0.7× 107 1.0× 33 767
Bogusz Trojanowicz Germany 17 100 0.3× 73 0.2× 304 1.1× 150 0.8× 81 0.8× 38 716
Francisco Vidal Spain 19 109 0.3× 39 0.1× 440 1.5× 177 0.9× 68 0.6× 60 985
Kolade M. Agboola United States 9 141 0.4× 95 0.3× 340 1.2× 92 0.5× 78 0.7× 20 926
Vikas Sud United States 7 115 0.3× 84 0.3× 138 0.5× 53 0.3× 79 0.7× 10 765
Michael Sweeney United States 16 142 0.4× 161 0.5× 585 2.0× 58 0.3× 112 1.0× 35 884
Shigenari Hozawa Japan 11 167 0.5× 68 0.2× 299 1.0× 64 0.3× 193 1.8× 18 714
Seth B. Furgeson United States 15 194 0.5× 34 0.1× 512 1.8× 116 0.6× 69 0.6× 30 953
Mustafa Yalçınkaya United States 13 140 0.4× 58 0.2× 243 0.8× 86 0.4× 27 0.3× 22 579

Countries citing papers authored by Alison Marker

Since Specialization
Citations

This map shows the geographic impact of Alison Marker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Marker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Marker more than expected).

Fields of papers citing papers by Alison Marker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Marker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Marker. The network helps show where Alison Marker may publish in the future.

Co-authorship network of co-authors of Alison Marker

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Marker. A scholar is included among the top collaborators of Alison Marker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Marker. Alison Marker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paterson, Anna, et al.. (2021). Thyroid diagnostic modalities (fine needle aspiration and core needle biopsy) with histology correlation: a tertiary centre experience. Journal of Clinical Pathology. 75(9). 620–626. 2 indexed citations
2.
Fewings, Eleanor, Alison Marker, Olivier Giger, et al.. (2021). Investigating the clinical, pathological and molecular profile of oncocytic adrenocortical neoplasms: a case series and literature review. SHILAP Revista de lepidopterología. 1(1). 33–44. 1 indexed citations
3.
Wu, Xilin, Sumedha Garg, Claudia Cabrera, et al.. (2020). OR34-02 Somatic Transmembrane Domain Mutations of a Cell Adhesion Molecule, CADM1, Cause Primary Aldosteronism by Preventing Gap Junction Communication Between Adrenocortical Cells. Journal of the Endocrine Society. 4(Supplement_1). 1 indexed citations
4.
MacFarlane, James, et al.. (2019). A case of Birt-Hogg-Dube syndrome presenting with a rare oncocytic non-secretory phaeochromocytoma. Endocrine Abstracts. 1 indexed citations
5.
Casey, Ruth, Olivier Giger, Ian Seetho, et al.. (2018). Rapid disease progression in a patient with mismatch repair-deficient and cortisol secreting adrenocortical carcinoma treated with pembrolizumab. Seminars in Oncology. 45(3). 151–155. 23 indexed citations
6.
Challis, Benjamin, Narayanan Kandasamy, Andrew Powlson, et al.. (2016). Familial Adrenocortical Carcinoma in Association With Lynch Syndrome. The Journal of Clinical Endocrinology & Metabolism. 101(6). 2269–2272. 26 indexed citations
7.
Teo, Ada Ee Der, Sumedha Garg, Lalarukh Haris Shaikh, et al.. (2015). Pregnancy, Primary Aldosteronism, and AdrenalCTNNB1Mutations. New England Journal of Medicine. 373(15). 1429–1436. 92 indexed citations
8.
Masterson, Liam, et al.. (2015). Inverted papilloma of lacrimal sac invading into the orbit: Case report and review of literature. Journal of Cancer Research and Therapeutics. 11(1). 238–238. 8 indexed citations
9.
Masterson, Liam, Maral J. Rouhani, Neil Donnelly, et al.. (2014). Squamous Cell Carcinoma of the Temporal Bone. Otology & Neurotology. 35(3). 501–508. 31 indexed citations
10.
Azizan, Elena, Brian Lam, Stephen Newhouse, et al.. (2012). Microarray, qPCR, andKCNJ5Sequencing of Aldosterone-Producing Adenomas Reveal Differences in Genotype and Phenotype between Zona Glomerulosa- and Zona Fasciculata-Like Tumors. The Journal of Clinical Endocrinology & Metabolism. 97(5). E819–E829. 144 indexed citations
11.
Lynch, Magnus, et al.. (2004). Malignant eccrine poroma in breast cancer-related lymphoedema. Annals of The Royal College of Surgeons of England. 86(6). 32–35. 3 indexed citations
12.
Thompson, Michael P., et al.. (2004). A paediatric case of a solitary fibrous tumour of the parotid gland. International Journal of Pediatric Otorhinolaryngology. 68(4). 481–487. 11 indexed citations
13.
Taylor, C. Barr, et al.. (1997). Behcet's syndrome progressing to gastrointestinal perforation in a West African male. Lara D. Veeken. 36(4). 498–501. 5 indexed citations
14.
Bjarnason, Ingvar, Alison Marker, Chris Taylor, et al.. (1996). Intestinal inflammation, ileal structure and function in HIV. AIDS. 10(12). 1385–1391. 53 indexed citations
15.
Eden, Christopher, et al.. (1996). Human immunodeficiency virus‐related bacillary angiomatosis of the penis. British Journal of Urology. 77(2). 323–324. 3 indexed citations
18.
Lange, Aksel, M. Raafat El‐Maghrabi, Albert Tauler, et al.. (1989). Sequence of the 5′-flanking region of the rat 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase gene: Regulation by glucocorticoids. Biochemical and Biophysical Research Communications. 162(2). 753–760. 21 indexed citations
19.
Marker, Alison, et al.. (1973). [Antibody pattern in autoimmune hepatitis: clinical significance and differential diagnostic value].. PubMed. 79. 650–3. 1 indexed citations
20.
Marker, Alison, et al.. (1973). [Mitochondrial antibodies in nonhepatic diseases. Occurrence, significance and differential diagnosis].. PubMed. 98(23). 1186–8. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026